| 摘要 |
<p>Chimeric molecules comprising receptor activator of NF-ºB ligand (RANKL) antibodies and parathyroid hormone/parathyroid hormone-related protein (PTH/PTHrP) peptides are described. Compositions and methods for the treatment of bone diseases are also described.</p> |
